You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
After a 54 percent quarter over quarter rise in sales of the test, Rosetta's CEO said that the realigned strategy will take the firm to profit more quickly.
The collaborators are developing tests for rectal cancer based on microRNA and messenger RNA signatures.
Researchers from Northwestern University uncovered five circulating microRNAs that differentiate patients with very high- and low-risk prostate cancer.
Muneesh Tewari, a former Fred Hutchinson Cancer Research Center scientist who recently moved to the University of Mic
A research team led by investigators at Rockefeller University has developed a new method for detecting microRNAs in tissue samples, demonstrating its ability to differentiate skin cancer types based on tumor-specific miRNA signatures.